← Back to Analyst Consensus 
QNCX Buy
IRulya Therapeutics Inc.
Current Price —
Implied Upside —
Analysts 13
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 9, 2026 | Raymond James | initiate | — → Outperform | — | 53% |
| Sep 24, 2026 | Rodman & Renshaw | initiate | — → Buy | — | 40% |
| Sep 22, 2026 | Citizens | upgrade | Market Perform → Market Outperform | — | 47% |
| Aug 18, 2026 | Cantor Fitzgerald | reiterate | Overweight → Overweight | — | 50% |
| Jul 29, 2026 | Oppenheimer | initiate | Outperform → Outperform | — | 52% |
| Jun 24, 2026 | Leerink Partners | initiate | — → Outperform | — | 51% |
| Jun 23, 2026 | Cantor Fitzgerald | initiate | — → Overweight | — | 50% |
| Jan 30, 2026 | Citizens | downgrade | Market Outperform → Market Perform | $0 | 47% |
| Jan 30, 2026 | D. Boral Capital | downgrade | Buy → Hold | $0 | 34% |
| Jan 29, 2026 | D. Boral Capital | maintain | Buy → Buy | $5 | 34% |
| Dec 15, 2025 | D. Boral Capital | maintain | Buy → Buy | $5 | 34% |
| Nov 13, 2025 | D. Boral Capital | maintain | Buy → Buy | $4 | 34% |
| Sep 26, 2025 | D. Boral Capital | maintain | Buy → Buy | $4 | 34% |
| Aug 15, 2025 | D. Boral Capital | maintain | Buy → Buy | $4 | 34% |
| Aug 12, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $8 | 53% |
| Aug 5, 2025 | JMP Securities | initiate | — → Market Outperform | $9 | 53% |
| Jul 17, 2025 | D. Boral Capital | maintain | Buy → Buy | $4 | 34% |
| Jun 13, 2025 | D. Boral Capital | maintain | Buy → Buy | $4 | 34% |
| Jun 4, 2025 | D. Boral Capital | maintain | Buy → Buy | $4 | 34% |
| Mar 25, 2025 | D. Boral Capital | maintain | Buy → Buy | $4 | 34% |
| Mar 24, 2025 | Oppenheimer | initiate | — → Outperform | $10 | 52% |
| Feb 5, 2025 | D. Boral Capital | maintain | Buy → Buy | $12 | 34% |
| Jan 2, 2025 | D. Boral Capital | maintain | Buy → Buy | $12 | 34% |
| Dec 18, 2024 | Brookline Capital | initiate | — → Buy | $9 | 38% |
| Nov 14, 2024 | D. Boral Capital | maintain | Buy → Buy | $12 | 34% |
| Nov 12, 2024 | D. Boral Capital | maintain | Buy → Buy | $12 | 34% |
| Nov 7, 2024 | Maxim Group | initiate | — → Buy | $6 | 41% |
| Oct 29, 2024 | Rodman & Renshaw | initiate | — → Buy | $11 | 40% |
| Oct 22, 2024 | EF Hutton | initiate | — → Buy | $12 | 30% |
Price Target Trend
May 12, 2026 Oct 27, 2026
EPS Estimates
+1q —
0y —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days